- Report
- January 2024
- 200 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- January 2024
- 200 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- March 2022
- 300 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- February 2024
- 175 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- February 2024
- 175 Pages
Global
From €3938EUR$4,000USD£3,266GBP
- Report
- January 2024
- 200 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- November 2023
- 175 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- October 2023
- 113 Pages
Global
From €5858EUR$5,950USD£4,859GBP
- Report
- September 2023
- 120 Pages
North America
From €5858EUR$5,950USD£4,859GBP
- Report
- January 2024
- 150 Pages
Global
From €4775EUR$4,850USD£3,961GBP
- Report
- May 2023
- 260 Pages
Global
From €2609EUR$2,650USD£2,164GBP
- Report
- September 2020
- 120 Pages
Global
From €2461EUR$2,500USD£2,042GBP
- Report
- January 2023
- 50 Pages
China
From €2954EUR$3,000USD£2,450GBP
From €2560EUR$2,600USD£2,123GBP
- Report
- May 2021
- 50 Pages
China
From €2560EUR$2,600USD£2,123GBP
- Report
- November 2023
- 250 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- January 2024
- 175 Pages
Global
From €4923EUR$5,000USD£4,083GBP
- Report
- October 2021
- 215 Pages
Global
From €4381EUR$4,450USD£3,634GBP
- Report
- September 2022
- 111 Pages
From €3397EUR$3,450USD£2,817GBP
- Report
- September 2022
- 136 Pages
Europe
From €3397EUR$3,450USD£2,817GBP

The Urological Disorders Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat urological disorders. These disorders include urinary tract infections, bladder control issues, kidney stones, prostate cancer, and erectile dysfunction. Companies in this market develop and market drugs that can help to reduce the symptoms of these disorders, as well as provide treatments for them.
Some of the major players in the Urological Disorders Drugs market include Pfizer, Merck, AstraZeneca, GlaxoSmithKline, and Sanofi. These companies have a wide range of products that are used to treat urological disorders, including antibiotics, antifungals, and anti-inflammatory drugs. Additionally, they have developed drugs that can help to reduce the symptoms of these disorders, such as pain relievers and muscle relaxants. Show Less Read more